Aprea Therapeutics, Inc. (APRE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1250300,
    "name": "Aprea Therapeutics, Inc.",
    "stock_name": "Aprea Therapeutics, Inc.",
    "full_name": "Aprea Therapeutics, Inc.",
    "name_url": "stocks-analysis/aprea-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.06",
    "chg": 0.04,
    "chgp": "3.92%",
    "dir": 1,
    "prev_price": "1.02",
    "mcapval": "9.38",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03836J2015",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "176.68 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aprea-therapeutics-inc-1250300-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Aprea Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-aprea-therapeutics-inc-technically-bullish-or-bearish-3548023",
        "imagepath": "",
        "date": "2025-09-20 20:08:05",
        "description": "As of 9 September 2025, the technical trend for Aprea Therapeutics, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength. Key indicators include a bearish signal from the daily moving averages and a bearish trend in both the weekly and monthly Bollinger Bands. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, while the KST is mildly bullish weekly but bearish monthly. The Dow Theory indicates a mildly bearish stance on both weekly and monthly time frames. \n\nIn terms of performance, Aprea has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -54.41% compared to the S&P 500's 12.22%, and a one-year return of -47.55% versus 17.14%...."
      },
      {
        "title": "Is Aprea Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-aprea-therapeutics-inc-overvalued-or-undervalued-3544204",
        "imagepath": "",
        "date": "2025-09-20 18:40:29",
        "description": "As of 12 August 2025, the valuation grade for Aprea Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.57 and an EV to EBITDA ratio of 0.63, which suggest that the market is not valuing the company favorably compared to its peers. Additionally, the Return on Capital Employed (ROCE) is exceptionally high at 631.77%, but this is misleading due to the negative Return on Equity (ROE) of -83.51%.\n\nIn comparison to its peers, Aprea Therapeutics has a lower EV to EBITDA ratio than Cosmos Health, Inc. at -2.6396 and Lisata Therapeutics, Inc. at 0.1349, both of which are also classified as risky. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -54.41% compared to the index's 12.22%, reinfor..."
      }
    ],
    "total": 7,
    "sid": "1250300",
    "stock_news_url": "https://www.marketsmojo.com/news/aprea-therapeutics-inc-1250300"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Aprea Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:08:05

As of 9 September 2025, the technical trend for Aprea Therapeutics, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength. Key indicators include a bearish signal from the daily moving averages and a bearish trend in both the weekly and monthly Bollinger Bands. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, while the KST is mildly bullish weekly but bearish monthly. The Dow Theory indicates a mildly bearish stance on both weekly and monthly time frames. In terms of performance, Aprea has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -54.41% compared to the S&P 500's 12.22%, and a one-year return of -47.55% versus 17.14%....

Is Aprea Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:40:29

As of 12 August 2025, the valuation grade for Aprea Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.57 and an EV to EBITDA ratio of 0.63, which suggest that the market is not valuing the company favorably compared to its peers. Additionally, the Return on Capital Employed (ROCE) is exceptionally high at 631.77%, but this is misleading due to the negative Return on Equity (ROE) of -83.51%. In comparison to its peers, Aprea Therapeutics has a lower EV to EBITDA ratio than Cosmos Health, Inc. at -2.6396 and Lisata Therapeutics, Inc. at 0.1349, both of which are also classified as risky. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -54.41% compared to the index's 12.22%, reinfor...

View All News